See how top analysts and institutions rate TMO — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Barclays | Upgrade | Equal Weight → Overweight | $550 | 2025-09-11 |
| William Blair | Initiated | Outperform | 2025-08-19 | |
| HSBC Securities | Downgrade | Buy → Hold | $510 | 2025-07-24 |
| Scotiabank | Upgrade | Sector Perform → Sector Outperform | $590 | 2025-07-11 |
| UBS | Downgrade | Buy → Neutral | $460 | 2025-07-09 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 5 | 13 | 7 | 0 | 0 |
| October 2025 | 5 | 14 | 6 | 0 | 0 |
| September 2025 | 5 | 16 | 6 | 0 | 0 |
| August 2025 | 6 | 16 | 7 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for TMO, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
